US Stocks
/
SAB Biotherapeutics, Inc. Warrant Share Price
SAB Biotherapeutics, Inc. Warrant Share Price

SAB Biotherapeutics, Inc. Warrant Share Price

NASDAQ: SABSW
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

SAB Biotherapeutics, Inc. Warrant Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

SAB Biotherapeutics, Inc. Warrant Share Price Chart

$0.00$0.00
L
Show Current Price
H

SAB Biotherapeutics, Inc. Warrant Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$0.22
Revenue (TTM)
N/A
Return On Equity (TTM)
8.76%
Profit Margin
N/A
Debt to Equity
0.07
Quarterly Earnings Growth YoY
539.11%

SAB Biotherapeutics, Inc. Warrant Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$263137.00N/AN/AN/AN/A
Net Profit-$5.03M-$7.34M-$10.35M-$5.20M-$10.11M$45.45M
Net Profit MarginN/A-2787.69%N/AN/AN/AN/A
Income ChangeN/A-45.96%-41.09%49.79%-94.63%549.32%

SAB Biotherapeutics, Inc. Warrant Annual Profit & Loss

All figures in USD

Particulars2021202320242025
Revenue$60.88M$2.24M$1.32M$0.00
Net Profit-$17.14M-$42.19M-$34.11M$13.27M
Net Profit Margin-28.16%-1884.50%-2579.03%N/A
Income ChangeN/A-146.11%19.17%138.92%

About SAB Biotherapeutics, Inc. Warrant

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

SAB Biotherapeutics, Inc. Warrant Historical Returns

MonthOpenCloseChange %

SABSW Share Price FAQs

What is SAB Biotherapeutics, Inc. Warrant share price today?

chevron-up
SAB Biotherapeutics, Inc. Warrant share price today is $0.00 as on August 30, 2026 at 10:19 am IST.

What is the 52 week high and 52 week low of SAB Biotherapeutics, Inc. Warrant stock?

chevron-up
52 week high/low data for SAB Biotherapeutics, Inc. Warrant is currently unavailable.

What is SABSW's net income for the last quarter?

chevron-up
SABSW's net income for the last quarter is 0.05B USD.

Can I buy SABSW shares in India?

chevron-up
Yes. You can buy SABSW in India by opening an international trading account.